FDA PMA Approved 🇺🇸 United States

PMA: P220016 · Decision Jun 18, 2026
Classifications
0
FEI Numbers
0
Registration Numbers
0

Basic Information

Trade Name
HepQuant SHUNT® Liver Diagnostic Test
PMA Number
P220016
Product Code
SIO
Generic Name
Test for Esophageal Varices
Advisory Committee
Clinical Chemistry
Decision
Approved
Decision Code
APPR
Decision Date
June 18, 2026
Date Received
September 14, 2022
Expedited Review
N

Advisory Committee Statement

Approval for HepQuant SHUNT® Liver Diagnostic TestThe HepQuant SHUNT® Liver Diagnostic Test is designed for the quantitative detection of 13C-cholate and d4-cholate in human serum from blood samples collected after the intravenous administration of 13C-cholate and the oral ingestion of d4-cholate. The assay generates a Disease Severity Index (DSI) score from the clearance of 13C-cholate and d4-cholate. Sample analysis is conducted by the HepQuant Analytical Test Laboratory.A DSI score below the validated threshold can be used in patients with compensated cirrhosis (Child Pugh Class A), age 22 years or older, undergoing screening or surveillance for esophageal varices to identify those patients unlikely to have large esophageal varices. The DSI score aids in identifying patients unlikely to require esophagogastroduodenoscopy (EGD) at the time of testing.The HepQuant SHUNT® Liver Diagnostic Test is not a stand-alone test and should be used in conjunction with other clinical and laboratory findings.